Histopathologic examination demonstrated a FIGO stage IA low-grade endometrioid carcinoma of the uterine corpus and a SMARCA4-deficient undifferentiated carcinoma of the ovary. Here, SMARCA4 is linked to endometrial endometrioid adenocarcinoma.